Peptonic's patented intimate cleanser to be sold in 293 Apoteket stores
Peptonic Medical AB (publ) ("Peptonic") announced today that the company's patented intimate wash, VagiVital Moisturizing V Cleanser, is being offered for sale in 293 Apoteket stores in Sweden.
”VagiVital Moisturizing V Cleanser is more than just an intimate wash as it also moisturizes, balances pH and does not disturb the delicate intimate microflora. It is very gratifying that Apoteket is recognizing this and now starts selling our preventive intimate wash in its physical stores. The agreement is yet another proof that our unique holistic concept of Diagnosing, Treating and Preventing attracts both end customers and distribution channels," said Peptonic's Sweden Manager Fanny Falkman Grinndal.
The global intimate cleanser market is approx. 1.2 billion USD on the consumer level, and growing at an annual rate of approx. 3,5%. Somewhat simplified, the market constitutes of soaps and oils. With soaps there is a risk of disturbing the vaginal microflora possibly leading to dryness and vaginal infections, and with oils there is a challenge to cleanse water soluble impurities. Peptonics intimate cleanser is positioned in between.
Based on the company’s clinically proven vaginal gel and a Nordic botanical oil, VagiVital Moisturizing V Cleanser allows cleansing of both water and oil soluble impurities. Unlike soaps Peptonics intimate wash is able to do this without surfactants which is also the reason why Peptonics product is patented and does not disturb the sensitive micro flora. VagiVital Moisturizing V Cleanser also moisturizes the intimate area and is recommended by gynecologists.
VagiVital Moisturizing V Cleanser will be available in Apoteket's stores in February 2024, and the agreement applies to distribution in 293 of Apoteket's physical stores.
”One year ago we had one product distributed in Apoteket physical stores, from February next year we will have four which shows a great and growing interest from retail channels and consumers in our portfolio strategy” said Erik Sundquist, CEO of Peptonic Medical.
The increased distribution of products in Apoteket AB is projected to add approx. 1 MSEK in annual sales for Peptonic Medical in Sweden.
For further information, please contact:
Erik Sundquist, CEO
Telefon: + 46 722 49 90 43
E-post: erik.sundquist@peptonicmedical.se
About PEPTONIC medical AB
Peptonic Medical AB is an innovative Swedish biomedical company engaged in research, development, and sales of unique medical treatments in the field of women's intimate health. Under the brand VagiVital®, the product portfolio encompasses treatments for various conditions such as vaginal atrophy, bacterial vaginosis, and urinary tract infections. These clinically tested products address the growing demand for intimate self-care within the business concept of Diagnose, Treat, Prevent. Sweden serves as the reference market to facilitate geographic expansion in collaboration with local distributors. The United States is the largest market in terms of sales. The company is headquartered in Stockholm, Sweden, with a sales office in New York, NY, and an R&D unit in Caesarea, Israel. Peptonic Medical also has a wholly owned subsidiary, Lune Oy, in Finland, focusing on sustainable period products sold under the Lunette®️ brand (www.lunette.com). The company's shares have been listed on www.spotlightstockmarket.com since 2014.